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IN VIVO AND IN VITRO ANTITUMOR EFFECTS OF NUTRIENT 
MIXTURE IN MURINE LEUKEMIA CELL LINE P-388
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Aim: Leukemia is characterized by uncontrolled marrow cell proliferation and metastatic foci. We investigated the antitumor po-
tential of a nutrient mixture on malignant leukemia P-388 cells. Methods: The nutrient mixture containing lysine, proline, ascorbic 
acid, green tea extract and other nutrients is formulated to target key pathways in cancer progression. The cells were treated with 
the mixture, and tested at doses 0, 10, 50, 100, 500 and 1000 μg/ml in triplicates. The effects were evaluated by cell proliferation, 
Matrigel invasion, cell morphology and apoptosis. The in vivo effect was measured in male nude mice (n = 12) inoculated with 
P-388 cells. After randomly dividing in two groups, each group was fed regular and the nutrient mixture supplemented diet and the 
mice were sacrificed after four weeks. Results: The nutrient mixture decreased P-388 cell proliferation at 500 and 1000 μg/ml. 
Only 10% cells were viable at 1000 μg/ml. Matrigel invasion was significantly inhibited in a dose dependent manner with virtually 
total inhibition at 1000 μg/ml. Cell morphological features notably changed with dose increase to 1000 μg/ml. Analysis of apop-
totic cells on live green caspase kit exhibited gradual increase with the increasing dose of the nutrient mixture, and at 1000 μg/
ml 92% of P-388 cells were in late apoptosis. Tumors in the group of mice supplemented with the nutrient mixture had 50% lower 
weight compared to the tumors in control group (p = 0.0105). Histopathologically, both the groups of tumors were similar, yet size 
of tumors in the group treated with the nutrient mixture was considerably smaller. Conclusion: These results indicate that the nutri-
ent mixture exhibited significant action against multiple targets in P-388 leukemia and may have potential in human leukemia.
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Leukemia, acute or chronic, is a malignancy 
of bone marrow characterized by uncontrolled pro-
liferation of while blood cells, resulting in formation 
of metastatic foci. The process of penetration through 
extra cellular matrix (ECM) barrier and blood vessel 
walls is often mediated through matrix metallopro-
teinases (MMPs) enzymes. Acute lymphoblastic/
lymphocytic leukemia (ALL) is a fast growing tumor 
of immature lymphocytes in the bone marrow, while 
chronic lymphocytic leukemia (CLL) is much slower 
developing malignancy of partially matured cells. 
Leukemic lymphocytes replace the normal marrow 
cells thereby diminishing red, white blood cells and 
platelets. Once diagnosed, lymphocytic leukemia rap-
idly invades and metastasizes to lymph nodes, spleen, 
liver, central nervous system and testis in males. 
Children in the first decade of life have the highest 
incidence of ALL and the incidence of all types of leu-
kemia increases with age. Some risk factors include 
genetic diseases like Down syndrome, blood disor-
ders as myelodysplastic syndrome, therapeutic and 
environmental exposure to chemicals and radiation. 
Viral infections with human T-cell lymphoma/leukemia 
virus-1 (HTLV-1) and Epstein-Barr virus (EBV) also 
increase the risk of this particular type of leukemia. 
Without treatment, most patients with ALL would live 
only few months. Although there are several treatment 
options available, ALL turns rapidly fatal in adults [1]. 
In 2010, the American Cancer Society estimated there 
would be 5,330 new cases of ALL diagnosed in the 
USA and 1,420 deaths would occur. While, only 25% 
of those diagnosed would be adults, 75% of those who 
die would be adult ALL patients [2]. Intense chemo-
therapy may help initial remission in 80–90% patients; 
yet, frequent relapses reduce the disease free survival 
rates to mere 30–40%. Although newer therapies are 
being developed for improving this statistics in children 
and adults, many of the chemotherapy options have 
damaging side effects. This is of critical importance 
in childhood leukemia, due to long-term reported 
side effects such as secondary malignancies in later 
life, cardiomyopathies, and neurological, endocrine 
as well as musculoskeletal dysfunctions. Therefore, 
we thought it would be helpful to evaluate natural 
compounds for their efficacy in leukemia treatment.  
Destruction of extracellular matrix (ECM) has been 
known as a precondition for cancer cell growth, inva-
sion and metastasis. Rath and Pauling [3] proposed 
intervention through natural inhibitors of plasmin-
induced proteolysis, such as lysine and analogues. 
Our previous studies have indicated that synergistic 
anticancer effect of ascorbic acid, proline, lysine, and 
epigallocatechin gallate (EGCG) was greater than that 
of the individual nutrients [4]. Further studies have 
proven significant anticancer activity of the combina-
tion of nutrients against a number of solid cancer cell 
lines by blocking cancer growth, tissue invasion, and 
MMPs expression both in vitro [4–6] and in vivo [7–9]. 
In the current study we investigated the antitumor 
potential of nutrient mixture (NM) mainly containing 
lysine, proline, ascorbic acid, and green tea extract 
and other nutrients, on lymphoblastic murine leukemia 
cell lines P-388 by measuring in vitro cell proliferation, 
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Matrigel invasion, modulation of MMPs expression, 
apoptosis and in in vivo studies. We used the NM com-
bination in P-388 leukemia cells, which is the mouse 
model used for highly malignant leukemia similar 
to acute leukemia in humans. The NM is a combination 
of several nutrients formulated to target the key physi-
ological pathways in cancer progression and metasta-
sis. For example, the ECM integrity is dependent upon 
adequate collagen formation and its stability. In this 
aspect ascorbic acid and the amino acids lysine and 
proline are necessary for the formation and optimum 
structure of collagen fibers. Manganese and copper 
are also essential cofactors in collagen formation pro-
cess. Collagen stability can be controlled by lysine [3] 
and by N-acetyl cysteine (NAC) through its inhibitory 
effect on MMP-9 activity [10] and invasiveness of tu-
mor cells [11]. In addition, selenium has been shown 
to interfere with MMP expression and tumor invasion 
[12] and to induce selective apoptosis of cancer 
cells. Ascorbic acid is proven to inhibit cell division 
and growth through production of hydrogen peroxide 
[13]. Green tea extract is known to be a promising 
agent in controlling angiogenesis, metastasis, and 
other aspects of cancer progression [14, 15]. Be-
cause arginine is a precursor of nitric oxide (NO), any 
deficiency of arginine can limit the production of NO, 
which predominantly acts as an inducer of apoptosis 
[16]. In addition we also found that a combination 
of ascorbic acid, lysine, and proline used with EGCG 
enhanced the anti-invasive activity of 20 μg/ml EGCG 
to that of 50 μg/ml [17]. Thus, by including NAC, ar-
ginine, selenium, manganese, and copper along with 
the combination of ascorbic acid, lysine, proline and 
EGCG, we could obtain significant reduction in cell 
invasion at a much lower concentration of EGCG 
or other components. Also, we have reported that the 
combined effects of these individual nutrients on de-
creasing proliferation of neoplastic cells were superior 
to the effects of each individual component or when 
they were randomly combined [18].
MATERIALS AND METHODS
Composition of nutrient mixture (NM). Stock 
solution of the NM prepared for testing was com-
posed of the following: vitamin C (as ascorbic acid, 
and as magnesium, calcium, and ascorbyl palmitate) 
700 mg; L-lysine 1000 mg; L-proline 750 mg; L-argi-
nine 500 mg; N-acetyl cysteine 200 mg; standardized 
green tea extract 1000 mg (green tea extract was de-
rived from green tea leaves obtained from US Pharma 
Lab.) The certificate of analysis indicates the following 
characteristics: total polyphenol 80%, catechins 60%, 
EGCG 35%, and caffeine 1.0%); selenium 30 mg; cop-
per 2 mg; manganese 1 mg.
In vitro study
Cancer cell line and cell culture. Leukemia 
P-388 cell line obtained from ATCC (American Type 
Culture Collection, Rockville, MD) was cultured 
in modified DEM media supplemented with 10% 
horse serum, and antibiotics (100 mg/ml penicillin 
and 100 mg/ml streptomycin from Gibco, BRL (Long 
Island, NY)). The cells were treated with the NM, dis-
solved in media and tested at 0, 10, 50, 100, 500 and 
1000 μg/ml NM in triplicate at each dose. Cell viability 
and cytotoxicity was assessed by Trypan blue dye 
exclusion test after 24 h. Viable cell count was ex-
pressed as a function of control. Phorbol 12-myristate 
13-acetate (PMA), 100 μg/ml, was added to the cells 
to induce MMP secretion. The plates were then re-
turned to the incubator.
Gelatinase Zymography. Gelatinase zymography 
was used to determine the MMPs activity in condi-
tioned media. Zymography was performed in 10% 
Novex precast SDS-polyacrylamide gel (Invitrogen 
Corporation, Carlsbad, CA) in the presence of 0.1% 
gelatin under non-reduced conditions. Culture media 
(20 μl) mixed with sample buffer was loaded and SDS-
PAGE was performed with Tris glycine SDS buffer 
as described by the manufacturer (Novex). Samples 
were not boiled before electrophoresis. Following 
electrophoresis, the gels were washed twice in 2.5% 
Triton X-100 for 30 min at room temperature to remove 
SDS. The gels were then incubated at 37 °C overnight 
in substrate buffer containing 50 mM Tris-HCl and 
10 mM CaCl2 at pH 8.0 and stained with 0.5% Coo-
massie Blue R250 in 50% methanol and 10% glacial 
acetic acid for 30 min and destained. Protein standards 
were run concurrently and approximate molecular 
weights were determined by plotting the relative mo-
bilities of known proteins. 
Invasion analysis using Matrigel. Invasion studies 
were conducted using Matrigel™ (Becton-Dickinson, 
Franklin Lakes, NJ) inserts in 24-well plates. Sus-
pended in medium, P-388 cells were supplemented 
with NM, as specified in the design of the experiment 
and seeded on the insert in the well. Thus, both the me-
dium on the insert and in the well contained the same 
supplements. The plates with the inserts were then 
incubated in a culture incubator equilibrated with 95% 
air and 5% CO2 for 24 h. After incubation, the media 
from the wells were withdrawn. The cells on the upper 
surface of the inserts were gently scrubbed. The outer 
surface of the insert was washed, and the media and 
washing were collected gently in the well. The media 
was spun and the cells were counted.
Morphology. Morphological studies were con-
ducted after 24 h treatment of the cells with NM at the 
concentrations ranging from 50–1000 μg/ml. The cells 
were stained by hematoxylin & eosin and examined 
by light microscopy.
Apoptosis. Apoptosis in NM treated cells was 
determined using Poly Caspase Detection Kit. Cells 
were challenged with the NM at 0, 50, 100, 500 and 
1000 μg/ml concentrations for 24 h. The culture was 
washed with PBS and treated with caspase reagent 
as specified in the manufacturer’s protocol (Molecular 
Probes Image–IT™ Live green Poly Caspase Detection 
Kit 135104, Invitrogen). Cells were examined by fluo-
rescence microscopy and counted. Green colored 
cells represent viable cells, while yellow orange colored 
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cells represent early apoptosis stage and red color 
represents late apoptosis stage. 
In vivo study
Experimental design: Male athymic nude mice 
(NCr-nu/nu), approximately 6 weeks of age, were pur-
chased from Simonsen Laboratories (Gilroy, CA) and 
maintained in micro-insulated cages under pathogen-
free conditions on a 12 h light/12 h dark schedule for 
a week. All animals were cared for in accordance with 
institutional guidelines for the care and use of experi-
mental animals.
After housing for a week, the mice (n = 12) were 
inoculated with 0.5 x 106 P-388 cells in 0.2 ml of PBS 
in the right flank. After injection, the mice were ran-
domly divided in two groups; group A was fed regular 
diet while group B was fed the regular diet supple-
mented with 0.5% of NM. During the study, the mice 
consumed, on an average, 4 g of their respective diets 
per day. Thus, the experimental animal received ap-
proximately 20 mg of NM per day. After 4 weeks, the 
mice were sacrificed and their tumor were excised and 
processed for histology.
Histology. Tissue samples were fixed in 10% buf-
fered formalin. All tissues were fixed in paraffin and 
cut at 4–5 μm slides. Sections were deparaffinized 
through xylene, dehydrated by alcohol and stained 
with hematoxylin and eosin (H&E) for evaluation using 
a standard light microscopy.
Statistical analysis. Results were expressed 
as means ± SD for the groups. Data was analyzed 
by independent sample “t” test.
RESULTS
In vitro studies
Cell proliferation study. NM was not tox-
ic to P-388 leukemia cells at concentrations 
up to 100 μg/ml and exhibited a dose response de-
cline in cell proliferation and viability at 500 μg/ml and 
1000 μg/ml. As seen from Fig. 1, only 70% and 10% 
cells were viable at 500 and 1000 μg/ml NM respec-
tively.
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Fig. 1. Effect of NM on cell proliferation of murine leukemia 
cell line P-388; NM exhibited no toxicity at concentrations 
up to 100 μg/ml; while the cell viability considerably decreased 
at concentrations 500 μg/ml and 1000 μg/ml
Gelatinase zymography. Zymography did not dem-
onstrate expression of MMP-2 or MMP-9 enzymes. 
No activity was detected even after treatment with 
PMA (100 ng/ml) (data not shown).
Invasion through Matrigel. The NM significantly 
inhibited invasion of P-388 cells through Matrigel 
compared with control. With increasing concentra-
tions, the inhibition of invasion progressed from 80% 
at 500 μg/ml to total inhibition at 1000 μg/ml (Fig. 2).
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Fig. 2. NM significantly inhibited Matrigel invasion of P-388 cells 
compared to the control. Virtually 100% inhibition was observed 
at 1000 μg/ml of NM
Morphology. Mild changes in P-388 cell morphol-
ogy were noticed at 500 μg/ml NM and significant 
changes were noted at 1000 μg/ml NM (Fig. 3).
Apoptosis analysis. Dose dependent NM effect 
on apoptosis of P-388 cells was observed (Fig. 4, 
a–e).  Moderate amount of cell apoptosis was ob-
served in cells exposed to 50 μg/ml NM and 100 μg/
ml NM (Fig. 4, b, c). However, the extent of apoptotic 
cells increased significantly with increasing doses 
of NM up to 1000 μg/ml. (Fig. 4, c–f) Quantitative 
analysis of live, early and late apoptotic cells is shown 
(Fig. 4, g). Exposure to 50 μg/ml NM resulted in 61% 
live cells and 19% late apoptotic cells, and along with 
the increasing concentrations of NM, the percentage 
of late apoptotic cells gradually increased up to 92% 
at 1000 μg/ml NM while the percentage of live cells 
decreased accordingly from 6% at 1000 μg/ml.
In vivo studies
Tumor growth. Nude mice supplemented for 
4 weeks with 0.5% NM in their diets, developed 
significantly smaller tumors than the control group 
as shown in Fig. 5. Tumors in NM supplemented mice 
demonstrated 50% lower weight compared to those 
developed in the control group of mice. The average 
weight of tumors in control group was 1.02 g versus 
0.54 g in the NM supplemented group (p = 0.0105). 
Nude mice from both groups showed no loss in body 
weight over the study period. 
Histopathology. Histopathological reports stated 
that the tumors from control animals were large and 
irregularly round and present in the dermis and subcu-
tis of the skin. The tumor is composed of solid sheets 
of irregularly round cells with large irregularly round 
hyperchromatic nuclei and scant bluish cytoplasm. 
These findings are consistent with malignant lym-
phoma. Mitotic figures are common as are irregular 
foci of tumor necrosis. The tumors from NM treated 
group of mice were reported to have similar histology, 
but their size was considerably smaller (Fig. 6).
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DISCUSSION
In this study, the use of NM demonstrated signifi-
cant inhibition of P-388 leukemia cells as measured 
by various in vitro and in vivo parameters. NM exhibited 
slight toxicity at 50 μg/ml and significant (70–90% 
over the control) antiproliferative effect at 500 and 
1000 μg/ml respectively. Matrigel invasion was inhib-
ited at 500 μg/ml NM by 80% and virtually complete 
inhibition was achieved at 1000 μg/ml NM. In vivo 
studies verified the efficacy of NM, and the tumors 
developed in NM treated mice were by 50% smaller 
than these in control group.
The studies have demonstrated that the invasive and 
metastatic abilities of cancer cell correlate with MMPs 
expression, and thus treatment methods aimed at the 
control of proteolytic activity of ECM allows the oppor-
tunity to focus on common mechanisms of metastasis, 
angiogenesis and tumor growth. Rath and Pauling [3] 
postulated that nutrients such as lysine and ascorbic 
acid (Vitamin C) could act as natural inhibitors of ECM 
proteolysis and, by stabilizing the connective tissue, 
have the potential to modulate tumor growth and me-
tastasis. Ascorbic acid, lysine, proline, manganese, 
and copper are correlated with the support of collagen 
formation and ascorbic acid and green tea extract 
have been linked to the MMPs expression of cancer 
cells. Although significant MMPs activity was not noted 
in the current P-388 cell study, the importance of MMPs 
in acute leukemia is important. Kuittinen [19] studied the 
role of MMPs in various types of leukemias. Cancer cells 
secrete proteases that can degrade the ECM. MMPs, 
especially MMP-2 and MMP-9 lead to the ECM degra-
dation, resulting in cancer progression [20]. 
The nutrients in NM can utilize their antitumor 
potential through several mechanisms, including the 
inhibition of MMPs as well as strengthening of connec-
tive tissue surrounding cancer cells, which can act as 
Tumor encapsulating effect”. The inhibitory effects 
of individual nutrients tested have been reported 
in clinical and experimental studies. Ascorbic acid has 
been reported to exert cytotoxic and antimetastatic 
actions on malignant cell lines [21–23], as well as its 
low levels are reported in cancer patients [24, 25]. 
The dose dependent inhibitory effect of NM on cell 
proliferation was consistent with its dose dependent 
a b
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Fig. 3. Effect of NM on morphology of P-388 cells. H&E morphology 
of cells showed mild changes at 50 μg/ml with gradually increasing 
changes notable up to 1000 μg/ml. (a: control, b: NM 50 μg/ml, c: 
NM 100 μg/ml, d: NM 500 μg/ml, e: NM 1000 μg/ml)
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inhibition through Matrigel as well as increased apop-
tosis. Higher intake of green tea is shown to be asso-
ciated with reduced risk of leukemia [26]. Individual 
case studies have also reported objective and positive 
clinical response in CLL patients [27]. 
Ascorbic acid, EGCG and lysine have been shown 
to induce apoptosis in HTLV-1 positive and negative 
leukemia cells, in three separate studies [28, 29, 30]. 
However, we thought that individual nutrients are not 
as potent as their synergy. Our previous studies have 
shown that synergistic anticancer effect of ascorbic 
acid, proline, lysine, and EGCG on several cancer cell 
lines in tissue culture were greater than that of indi-
vidual nutrients. In another study, the combination 
of the nutrients used in NM has also shown similar 
response in HTLV-1 positive leukemia cells [31]. The 
current study initiated to test this phenomenon, has 
proven that increasing concentrations of NM induced 
92% cell apoptosis. Moreover, in contrast to the 
chemotherapy, which causes indiscriminate cellular 
Apoptosis in P-388 cells
0
10
20
30
40
50
60
70
80
90
100
Co
nt
ro
l
50
 µ
g/
m
l
10
0 
µg
/m
l
25
0 
µg
/m
l
50
0 
µg
/m
l
10
00
 µ
g/
m
l
Treatment with NM
%
 o
f C
on
tro
l
Live cells
Early apoptotic cells
Late apoptotic cells
a b
c d
e f
g
Fig. 4. Effect of NM on apoptosis of P-388 cells. NM induced 
apoptosis of leukemia cells in a dose-dependent fashion: a: 
control; b: NM 50 μg/ml; c: NM 100 μg/ml; d: NM 250 μg/ml; e: 
NM 500 μg/ml; f: NM 1000 μg/ml. g: quantitative analysis of live, 
early and late apoptotic P-388 cells shows dose dependence 
with increasing NM doses. NM challenge at 50 μg/ml results 
in 61% live cells and 19% late apoptotic cells, while 1000 μg/
ml NM results in 92% cells in late apoptosis and only 6% live cells
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destruction and ECM damage, morphological studies 
have shown that even at the highest concentrations 
of NM the P-388 cancer cells were not affected show-
ing that this formulation is non-toxic to cells. The in vivo 
results further confirmed the findings when NM fed 
mice developed 50% smaller tumors. 
According to 2010 estimates, 43,050 patients are 
expected to be diagnosed with leukemia in the USA 
and 21,840 of them would die because of it. While 
there are medications that may modify the prognosis, 
all of the drugs cause damaging side effects. On this 
background, our study suggests that NM is a potential 
candidate for therapeutic evaluation in lymphocytic 
leukemia and could be a studied for other types of can-
cer as well.
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